IMR OpenIR
High nitrogen stainless steel drug-eluting stent - Assessment of pharmacokinetics and preclinical safety in vivo
Chen, Shanshan; Yao, Zhifeng; Guan, Yongbiao; Yang, Hui; Shahzad, M. Babar; Wu, Yizhe; Zhang, Bingchun; Shen, Li; Yang, Ke
2020-12-01
Source PublicationBIOACTIVE MATERIALS
Volume5Issue:4Pages:779-786
AbstractPharmacokinetic analyses were performed using 20 pigs for 120-days implantation, while one sirolimus-eluting stent was implanted into one of their coronary artery. At different time points, the residual sirolimus on the stent, delivered locally (to artery wall), regionally (to adjacent and downstream muscle) and systemically (to plasma and visceral organs), was detected throughout 120 days. Preclinical safety evaluation was performed using 32 pigs for 180-days implantation to study the safety of metal platform material and the effectiveness of sirolimus eluting coating on the HNS stent. The neointima area, restenosis rate and inflammatory grade for HNS and control group stents were detected and analyzed. Approximately 80% sirolimus was eluted from the sirolimus-eluting stents after 30-days implantation in vivo. Additionally, there was sustained sirolimus in the artery wall, cardiac muscle and heart throughout 120-days implantation, and sirolimus accumulated to the peak at 90-days implantation. It was inferred that the sirolimus eluting stent in this study was covered by neointima before 90days implantation, indicating that the sirolimus eluting coating on the HNS stent was safe and effective. Very little sirolimus was distributed in visceral organs after 14-days implantation. HNS sirolimus-eluting stent exhibited lower restenosis rate and lower inflammatory grade than control group, which verified that the sirolimus-eluting coating design in this study was reasonable and practical. In addition, there were no significant difference in restenosis rate and inflammatory score between HNS bare-metal stent and drug-eluting stents, illustrating that HNS has good bio-compatibility and is suitable to use as coronary artery stent material.
DOI10.1016/j.bioactmat.2020.06.006
WOS IDWOS:000562478100004
Citation statistics
Document Type期刊论文
Identifierhttp://ir.imr.ac.cn/handle/321006/82333
Collection中国科学院金属研究所
Recommended Citation
GB/T 7714
Chen, Shanshan,Yao, Zhifeng,Guan, Yongbiao,et al. High nitrogen stainless steel drug-eluting stent - Assessment of pharmacokinetics and preclinical safety in vivo[J]. BIOACTIVE MATERIALS,2020,5(4):779-786.
APA Chen, Shanshan.,Yao, Zhifeng.,Guan, Yongbiao.,Yang, Hui.,Shahzad, M. Babar.,...&Yang, Ke.(2020).High nitrogen stainless steel drug-eluting stent - Assessment of pharmacokinetics and preclinical safety in vivo.BIOACTIVE MATERIALS,5(4),779-786.
MLA Chen, Shanshan,et al."High nitrogen stainless steel drug-eluting stent - Assessment of pharmacokinetics and preclinical safety in vivo".BIOACTIVE MATERIALS 5.4(2020):779-786.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Chen, Shanshan]'s Articles
[Yao, Zhifeng]'s Articles
[Guan, Yongbiao]'s Articles
Baidu academic
Similar articles in Baidu academic
[Chen, Shanshan]'s Articles
[Yao, Zhifeng]'s Articles
[Guan, Yongbiao]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Chen, Shanshan]'s Articles
[Yao, Zhifeng]'s Articles
[Guan, Yongbiao]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.